Try our Advanced Search for more refined results

FDA Gets Dozens Of Complaints After Ranbaxy Recall

By Jeff Overley (February 15, 2013, 4:56 PM EST) -- In a potential boost for a proposed class action, patients using Ranbaxy Laboratories Ltd.'s generic version of Lipitor have submitted to regulators dozens of complaints, many involving intestinal hemorrhages and abdominal pain, after pills that could contain glass particles were recalled, records obtained by Law360 show....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!